Lung Cancer Growth Suppressed by Anticancer and Antifibrotic Drug Combo


Using a new 3D cell culture system, researchers at Academia Sinica, National Yang Ming Chiao Tung University, National Taiwan University Hospital, and National Taiwan University, have shown how blocking the activity of fibroblasts can help to treat lung cancer. The team’s studies found that efficacy of the anticancer drug cisplatin was increased when treatment was combined with the antifibrotic drug nintedanib. Addition of nintedanib improved cisplatin’s effects on suppressing the growth of cancer-cell spheroids and the invasion of cancer cells. Analyses indicated that nintedanib therapy was linked to altered expression of fibroblast genes associated with cell adhesion, invasion, and ECM degradation.

“Our results suggest that the combination of nintedanib and cisplatin could be an effective treatment strategy for lung cancer by targeting both cancer cells and cancer-associated fibroblast activation surrounding the tumor,” said research lead Chau-Hwang Lee, PhD. at Academia Sinica, and National Yang Ming Chaio Tung University. The authors reported on their findings in APL Bioengineering, in a paper titledA 3D culture system for evaluating the combined effects of cisplatin and anti-fibrotic drugs on the growth and invasion of lung cancer cells co-cultured with fibroblasts.”

Fibroblasts build and maintain the extracellular matrix (ECM), or physical scaffolding for cells, in the connective tissues within the body. It is believed that cancerous tumors can recruit nearby fibroblasts and use them to promote their own growth and invasion. This process, called cancer-associated fibroblast (CAF) activation, can also protect tumors from chemotherapy and make treatment difficult. “The extracellular matrix (ECM) surrounding a solid tumor plays important roles in tumor progression and therapeutic efficacy,” the authors wrote. “In the tumor microenvironment (TME), cancer-associated fibroblasts (CAFs) facilitate the production of various cytokines in favor of cancer cell proliferation and metastasis. CAFs also alter the ECM’s properties and affect tumor progression and therapy resistance.”

Lee added, “Nearly 90% of late-stage lung cancer patient deaths are caused by the spread of tumors to other organs, rather than the primary tumor. Therefore, it is crucial to find ways to inhibit lung cancer metastasis to prolong the lives of lung cancer patients.”

Assessing the effects of changes to the ECM modulations on anticancer drug effects in vivo is challenging, however, the team noted. “Therefore, an in vitro model with a satisfactory predictive capacity is highly desirable for evaluating the efficacy of antitumor therapies.”

To simulate the tumor microenvironment and mimic real tissues, the team co-cultured lung cancer cells and fibroblasts in a 3D matrix comprised of Matrigel and fibrin, which simulated the tissue microenvironment around a solid tumor. In this 3D environment the cancer cells formed spheroids, around which the fibroblasts were randomly distributed.

The researchers tested the effects on the cancer cells of treatment using cisplatin (CDDP) with and without two anti-fibrotic drugs, nintedanib (NTD) and pirfenidone (PFD). Measuring indicators of tumor growth and invasiveness, they found that nintedanib improved the anti-cancer efficacy of cisplatin. Pirfenidone did not show a similar effect.

“Our results suggest that the combination of nintedanib and cisplatin could be an effective treatment strategy for lung cancer by targeting both cancer cells and cancer-associated fibroblast activation surrounding the tumor,” said Lee.

The studies found that the antifibrotic drug changed the expression of certain fibroblast genes. “We identified the expression of four genes relevant to cell adhesion, invasion, or ECM degradation that were reduced by NTD but increased or unaffected by PFD,” the investigators wrote. And while further studies will be needed to look more closely at the signalling pathways of proteins encoded by the genes under NTD or PFD treatment, the scientists noted, “RNA sequencing data suggest that the effects of NTD on CAFs could be more suppressive than PFD in terms of cell adhesion, invasion, or ECM degradation.”

Clinical and preclinical in vivo studies have previously indicated that NTD can improve the effects of certain anticancer drugs against lung cancers, the authors further noted. “The results of these clinical trials and the in vivo test are in agreement with that of our 3D co-culture experiments, supporting that NTD could improve the efficacy of anticancer drugs.”

The researchers believe that their 3D cell culture system will represent a valuable tool for assessing the efficacy of other drug combinations on tumor growth and invasion, and could feasibly eliminate the need for animal testing, while still reliably evaluating drug efficacy and safety. “This study could pave the way for the development of more effective treatment strategies for lung cancer and other solid tumors,” said Lee. “It is our hope that this study will introduce a new, promising tool for preclinical drug testing.”

The authors plan to study other types of cancers, such as liver and oral cancer, using the same system. “This fibrin/Matrigel co-culture system could be useful for evaluating the effects of drug combinations on various types of tumors related to tissue fibrosis, such as lung cancer, liver cancer, and oral cancer,” they concluded. “Further studies on drug-combination evaluations with patient-derived tissues cultured in fibrin/Matrigel are required.” The team also hope to improve the culture to better mimic the tumor microenvironment.

Berries are some of the best anti-cancer foods you’ll ever find


Image: Berries are some of the best anti-cancer foods you’ll ever find

If you’re constantly on the lookout for ways to reduce your cancer risk, welcome to the club. With so many different types of cancer to worry about and so few safe and effective treatments, prevention really is better than cure. Most natural foods possess anti-cancer benefits to some degree, but if you want to get the most benefits, you should head straight for the berry aisle at your grocery store or farmer’s market.

Your first clue that berries possess remarkable properties is their color. Many fruits that are deep purple, red and blue get their shade from anthocyanins. These powerful antioxidants help fight free radicals and curb the oxidative stress and inflammation at the heart of many types of cancers as well as degenerative diseases.

While they boast a lot of useful benefits, like preventing the buildup of plaque in arterial walls that can lead to heart disease, anthocyanins’ crowning achievement is their ability to prompt various types of cancer cells to kill themselves. They also have the power to interfere with tumors’ abilities to resist chemotherapy, helping make this often-ineffective treatment that much more useful.

It’s no surprise, then, that acai berries, with their incredible antioxidant content, have been shown in studies to inhibit cancer. They can be especially useful when fighting colon cancer; a study in the Journal of Agricultural and Food Chemistry found that acai could suppress the growth and reproduction of colon cancer cells in humans by a remarkable 90 percent.

That doesn’t mean you should seek acai at the expense of other berries, however. Bilberries might not be as glamorous as other superfoods, but they are still worthwhile, especially in those who have breast or intestinal cancer cells as studies have shown they can cause cell death in these cancers. Also known as the European blueberry, they are like smaller versions of the typical blueberry and can be used in any way you would use the more familiar fruit.

The power of the elements: Discover Colloidal Silver Mouthwash with quality, natural ingredients like Sangre de Drago sap, black walnut hulls, menthol crystals and more. Zero artificial sweeteners, colors or alcohol. Learn more at the Health Ranger Store and help support this news site.

Another more obscure berry, the chokeberry, puts many other fruits to shame. According to a 2012 study in Oncology Reports, the berries were able to cause malignant brain tumor cells to die. That study looked at the combination of these berries and curcumin. While curcumin fared well when it came to inducing cell death, chokeberries were completely lethal to the cancer cells while also inhibiting the expression of genes that help cancer to spread.

Raspberries, meanwhile, offer a double-pronged approach to fighting cancer. In addition to their high anthocyanin content, they also have a high amount of ellagitannins, enabling them to limit colon cancer cells’ invasiveness and spur cell death in prostate, breast, oral and cervical cancer. Ellagic acid attacks cancer from several angles, acting not only as an antioxidant but also helping to slow cancer cell reproduction and deactivate carcinogens.

Berries’ benefits extend beyond their antioxidant abilities

The American Institute for Cancer Research points out that berries are also excellent sources of vitamin C, which has been shown to help protect against esophageal cancer. They also contain a lot of fiber, which can lower your risk of colorectal cancer.

When you consider all these benefits, combined with the fact that berries happen to be delicious, it might be tempting to get as much of them into your system as possible. Eating berries is unlikely to hurt you, unless you happen to be allergic to them. However, it’s important to keep in mind that berries contain astringent tannins, so taking high doses of very concentrated berry extracts could be damaging over time. Use common sense and talk to a naturopath if you’re concerned about striking a healthy balance.

Sources for this article include:

NaturalHealth365.com

AICR.org

Naturalpedia.com

CONFIRMED: Quercetin-tocotrienols combination combats cancer


Image: CONFIRMED: Quercetin-tocotrienols combination combats cancer

The battle against cancer is heading into new territory, as scientists explore the healing ability of substances that support the body’s cells, instead of killing them off. Researchers from the Italian National Institute of Health and Science on Aging (INRCA) have made a breakthrough discovery for preventing the spread of malignant tumors. A natural plant-based combination, including quercetin and tocotrienols, effectively targets aging cells that cause chronic inflammation and cancer. This dynamic, anti-cancer duo causes stubborn cancer cells to die off and simultaneously promotes the growth of normal cells.

This dynamic duo heals the body at the cellular level by triggering a die-off sequence within aging and malignant cells. If old, decrepit cells become inefficient at performing cellular division, new cells cannot be created. If these senile cells refuse to die off, a condition called cellular senescence sets in. This causes an accumulation of aged cells that emit pro-inflammatory chemicals into the body. This process promotes aging in the body and increases cancer risk. Quercetin and tocotrienols help to remove aging cells so healthy cells have space to flourish.

Moreover, quercetin and tocotrienols identify malignant cancer cells and speed up their cellular senescence. This dynamic duo effectively target unwanted cancer cells and speed up their death, preventing cancer cell replication. The two natural substances remove inflammatory, aging cells and stop malignant cells from growing. This combination is a highly intelligent form of medicine that deciphers dangerous cells and manipulates cellular senescence so that the body can heal itself. The combination can be employed as an adjunct therapy for cancers of many origins. This combination can be used to prevent cancer from taking hold and stop early cancers in their tracks.

The power of the elements: Discover Colloidal Silver Mouthwash with quality, natural ingredients like Sangre de Drago sap, black walnut hulls, menthol crystals and more. Zero artificial sweeteners, colors or alcohol. Learn more at the Health Ranger Store and help support this news site.

Anti-cancer intelligence of tocotrienols

Tocotrienols are an anti-inflammatory type of vitamin E that can be found in wheat germ, barley, oat, rye, cranberries, blueberries, kiwi, plum, coconut, and some nuts. It is also isolated in supplement form. Research confirms that this form of vitamin E can reverse cell cycle arrest and reduce DNA damage, especially for treatment of breast cancer, pancreatic cancer, and melanoma. However, assimilation of tocotrienols in the human intestine is poor because they are lipophilic in nature (they dissolve in lipids and fats). Researchers must find ways to increase the bio-availability of tocotrienols to increase this vitamin’s therapeutic effects. Intestinal absorption depends upon the secretion of bile and transporters such as ?-tocopherol transfer protein (?-TTP); therefore, assimilation of tocotrienols occurs more readily with food. Nutritionists recommend a daily dose of 150 mg of tocotrienols. One should expect to see therapeutic benefits with supplementation after ninety days.

The healing nature of quercetin

Quercetin is a plant-based flavonoid and antioxidant that helps plants defend against disease. When quercetin is combined with tocotrienols, synergy is created; together these natural substances slow the aging process, prolong the life of healthy cells, and induce apoptosis of malignant cancer cells. Because of its anti-inflammatory properties, quercetin can benefit seasonal allergies, asthma, bronchitis, and congestion. Quercetin is commonly found in apples, tea, onions, nuts, berries, cauliflower and cabbage and can be isolated and consumed in the form of a supplement. To rid the body of aging cells, nutritionists recommend a daily dose of quercetin (500 to 800 mg) for up to three consecutive months, followed by a maintenance dose of 150 mg a day. It is best to consult a healthcare professional, as many medications can adversely interact with the body when healing substances are introduced.

Sources include:

NaturalHealth365.com

NCBI.NLM.NIH.gov

NaturalPedia.com

NaturalPedia.com

Pharmacology.Imed.Pub

Dramatically reduce your breast cancer risk by simply eating more cruciferous vegetables


Image: Dramatically reduce your breast cancer risk by simply eating more cruciferous vegetables

The odds of a woman developing breast cancer are downright frightening, with one out of every eight women expected to develop invasive breast cancer at some time in her life. Although there’s no way to guarantee you won’t be one of them, there are quite a few things you can do to stack the odds in your favor.

As the second leading cause of death in the U.S., cancer has been the subject of a lot of research. One thing that scientists have consistently found to reduce a person’s chances of developing breast cancer is consuming cruciferous vegetables. Epidemiological studies have found that women who eat cruciferous vegetables each day can reduce their breast cancer risk by as much as 50 percent.

Experts believe that cruciferous vegetables have this effect because they are high in an organosulfate compound known as sulforaphane. Studies have shown that sulforaphane can not only lower your risk of getting cancer and reduce the inflammation that can trigger the disease, but it also kills cancer cells outright. This overachieving compound can also prevent the DNA changes that lead to cancer and deactivate enzymes that transform pro-carcinogens into active carcinogens.

A 2007 Johns Hopkins University study found that sulforaphane inhibits the growth of four different types of breast cancer cells. It’s not just women who can benefit; it has also been shown in studies to significantly slow the development of prostate cancer in men. For example, one study showed that consuming just 60 milligrams of sulforaphane per day in the form of broccoli sprouts was enough to slow the doubling rate of prostate cancer by 86 percent.

In addition to reducing breast cancer and prostate cancer risk, studies haves demonstrated that sulforaphane supports gut health, helping people to maintain a healthy digestive system. It can also help enhance your body’s natural detox process, and it has even been shown to reduce muscle pain after exercise. Another study found that it helps prevent the type of oxidative damage seen in the body that leads to immune system decline as people age.

The best way to get sulforaphane

If you’d like to get these benefits for yourself, there are lots of cruciferous vegetables to choose from, including broccoli, cabbage, kale, mustard greens, Broccoli sprouts, bok choy, and watercress. It’s easy to incorporate these vegetables into your diet, and there are enough different options that you won’t have to worry about getting tired of eating the same thing all the time.

However, if you want to get the most bang for your buck, experts say you should turn to broccoli sprouts. Just 140 grams of the raw sprouts are enough to give you the amounts of sulforaphane seen in many of these studies. If you can’t find organic broccoli sprouts in your local farmer’s market or grocery store, you can make them yourself easily with broccoli sprouting seeds and a glass jar.

Although it’s better to eat cruciferous vegetables raw if you’re looking for their cancer-fighting benefits, it is okay to cook them as long as you don’t overdo it. Avoid boiling them as this inactivates the enzyme that transforms the glucoraphanin in the vegetables into sulforaphane. Instead, steam them lightly for no longer than four minutes.

As more information comes to light about simple dietary changes that can reduce our risk of disease, one can only hope that breast cancer will be far less common in the future than it is now. Consuming the foods that lower your cancer risk should be part of an overall healthy diet and lifestyle, but it’s safe to say that eating cruciferous vegetables requires such a small effort for such a great potential reward.

Sources for this article include:

NaturalHealth365.com

NaturalNews.com

High doses of vitamin C aggressively kill cancer cells, research confirms


 

Image: High doses of vitamin C aggressively kill cancer cells, research confirms

If you’ve heard that high doses of vitamin C can kill cancer, there’s a good chance you’ve also heard some official-sounding organizations claiming that there is no science to back this up. However, new research shows that high doses of vitamin C can indeed fight cancer, underscoring the findings of countless other studies like it that are widely ignored by the medical industry.

Detractors choose to focus on those studies that showed it didn’t work, conveniently ignoring the fact that many of the studies that were inconclusive in this regard simply weren’t testing big enough doses to unlock its effectiveness.

Research carried out at the University of Iowa confirms that vitamin C does kill cancer cells selectively without damaging normal cells. One study showed that the vitamins can reduce mutations that cause cancer in mice, while another study showed it can kill as much as 50 percent of human lymphoma cells.

Another study, this one from the Perlmutter Cancer Center, found that injecting mice with high doses of vitamin C stopped leukemia cancer stem cells from humans from growing, probably by telling the faulty stem cells in bone marrow to die. A different study found that adding vitamin C via IV to typical chemotherapy drugs extended the average survival times of pancreatic cancer patients from 5.65 months to 12 months.

Then there’s the University of Kansas study that injected high doses of vitamin C into ovarian cells from humans. They found that the vitamin targeted the ovarian cancer cells without harming healthy cells, and they went on to repeat the study on mice and human subjects.

The power of the elements: Discover Colloidal Silver Mouthwash with quality, natural ingredients like Sangre de Drago sap, black walnut hulls, menthol crystals and more. Zero artificial sweeteners, colors or alcohol. Learn more at the Health Ranger Store and help support this news site.

These findings wouldn’t be surprising to the researchers who worked on a review that was published in the Puerto Rico Health Sciences Journal in 2008. After looking at studies that used extremely higher amounts of vitamin C intravenously, they concluded that it can be effective against tumors, although they said that its efficacy could not be judged when it was administered orally.

Even though the authors called for further research into vitamin C’s cancer-fighting power, nothing was done about it at the time. After all, chemotherapy has been so profitable for the medical and pharmaceutical industries, and it would be hard to profit off of something as cheap, widely available, and unpatentable as vitamin C .

IV may not be the only way to deliver high doses of vitamin C

Some people have been getting these treatments on their own at alternative cancer clinics, but it’s not widely accepted. In addition, those who are wary of IVs find it extremely difficult to get the high blood concentration needed for this treatment to work its magic when they take it orally.

Now, however, there is a new form of vitamin C that could change everything. Liposomal vitamin C can create vitamin C levels in the blood that are 100 to 500 times greater than those normally achieved by oral ingestion, making it easier for people to fight cancer.

Liposomal vitamin C is encapsulated in lecithin, which shields it from digestive enzymes that would normally break it down. It makes its way through the digestive system with ease and is absorbed by the intestines before being transported into the liver, where it is released into the bloodstream.

This approach does away with the waste and gastric upset seen with conventional vitamin C tablets while maintaining high blood concentrations. Whether it will one day make its way into the mainstream and give riskier treatments like chemotherapy a run for their money remains to be seen, however.

Sources for this article include:

NaturalHealth365.com

NaturalNews.com

NaturalNews.com